Buy Braunovidon ointment is a disinfectant drug. The active substance of the preparation is povidone with 10% iodine content. The ointment is indicated for use on damaged or infected skin and in order to avoid infection.
Composition Braunovidon ointment:
Active substance: povidone with 10% iodine content (Povidonum iodinatum). 100 g of ointment contains 10 g of iodinated povidone and excipients: macrogol 400, macrogol 4000, purified water, sodium bicarbonate.
Action Braunovidon ointment:
A disinfecting drug for use on damaged skin, e.g. for burns, superficial skin defects, bedsores, as well as for infected skin, e.g. with purulent lesions, as well as fungal and bacterial skin diseases. The ointment can also be used to prevent skin infections. Braunovidon ointment contains povidone with 10% iodine content. Due to iodine, the ointment is brown in color. The color indicates the effectiveness of the iodine, the discoloration means that a new layer of the preparation is required.
Buy Braunovidon Application:
Braunovidon ointment indicated for use in the case of skin burns (hot fluid or fire), infected ulcers, pressure ulcers, infected superficial skin lesions that do not heal with inflammation or deeper ulceration, purulent skin lesions (pyoderma), diseases skin of bacterial or fungal origin, as well as secondary infections with the same agent previously treated.
Additional information:
Store the product out of reach of children, at room temperature. It is recommended to protect against moisture and light. Due to the risk of burns with mercury iodide, iodized povidone should not be used simultaneously with preparations containing mercury derivatives or after their use. It is not recommended to use the drug on a regular basis in people who are undergoing lithium therapy. Symptoms of iodine poisoning may occur if the drug is used in high doses on large areas of the skin, on wounds or burns. The simultaneous use of ointments and products with enzymes for dressing wounds causes oxidation of the enzyme components, making them ineffective. Do not use simultaneously with reducing agents, alkaloid salts, tannic acid, salicylic acid, silver salts, bismuth salts, taurolidine and hydrogen peroxides. Use during pregnancy and breastfeeding: the possibility of using the drug should be discussed with your doctor, however, until the 9th week of pregnancy, the drug should be used only if there are important indications for this. After the 9th week and during pregnancy, the use of the drug is contraindicated.
Contraindications:
Do not use in case of hypersensitivity to any component of the drug, including hypersensitivity to iodine. Do not use in the case of diseases of the thyroid gland. Do not use before or after treatment with radioactive iodine (until the end of therapy). Do not use in the case of herpetic dermatitis syndrome. Do not use under 6 months of age.
Side effects:
Some people may experience side effects during treatment. Skin and subcutaneous tissue disorders - frequency unknown: due to the cytotoxic effect of the drug, long treatment may adversely affect the wound healing process and temporary pain, burning sensation and heat may occur. Late allergic contact reaction (symptoms such as itching, redness, blisters) have been observed in a few cases. Immune system disorders - very rare: anaphylactic reactions. Endocrine disorders - frequency unknown: thyroid dysfunction, when applied to a large area of the body or repeatedly, especially on the damaged area of the skin. Renal and urinary disorders - frequency unknown: renal failure.
Dosage of Braunovidon ointment:
Use as directed by your doctor or as indicated on the leaflet. Apply the ointment several times a day, apply to the surface of the skin that requires treatment, covering it very carefully. In the first phase of treatment - to maintain the optimal bactericidal effect - the drug should be applied every 4-6 hours to the infected or oozing wound. Duration of treatment: depends on the clinical condition of the patient. The drug may remain on the skin for a long time. The dressing should be changed when the brown color of the ointment becomes discolored.